← Back to Search

Other

Ketone Supplement for Ketosis

Phase 2 & 3
Waitlist Available
Led By Corinde E Wiers, Ph.D.
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Meets current DSM-5 criteria for AUD and admitted for alcohol withdrawal management treatment at Caron Treatment Center
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 days
Awards & highlights

Study Summary

This trial tests if a ketone supplement can reduce symptoms of alcohol withdrawal during treatment.

Who is the study for?
This trial is for individuals undergoing clinical treatment for acute alcohol withdrawal. Participants should be experiencing symptoms of alcohol withdrawal and are currently in a treatment program.Check my eligibility
What is being tested?
The study aims to compare the effects of Kenetik, a ketone supplement, with an inactive placebo beverage on managing symptoms during the first 5 days of alcohol withdrawal treatment.See study design
What are the potential side effects?
Potential side effects were not provided. Typically, side effects from supplements like Kenetik could include digestive discomfort or allergic reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am diagnosed with alcohol use disorder and am getting treatment for withdrawal.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effects of ketone supplement Kenetik, three times daily (TID), versus placebo, on the need for benzodiazepines (daily use in mg).
Secondary outcome measures
Effects of ketone supplement Kenetik, three times daily (TID), versus placebo, on Clinical Institute Withdrawal Assessment Alcohol Scale Revised (CIWA-Ar) scores (daily maximum scores).

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Ketone SupplementActive Control1 Intervention
Ketone Supplement drink with 10 g ketones three times daily for five days.
Group II: Placebo BeveragePlacebo Group1 Intervention
Matching Placebo drink three times daily for five days

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,005 Previous Clinical Trials
42,882,237 Total Patients Enrolled
2 Trials studying Ketosis
40 Patients Enrolled for Ketosis
Corinde E Wiers, Ph.D.Principal InvestigatorUniversity of Pennsylvania
2 Previous Clinical Trials
40 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I be considered as a participant for this research endeavor?

"In order to qualify for this study, applicants must have ketosis and be within the age range of 18-75. 50 individuals will ultimately partake in the research trial."

Answered by AI

Is this experiment still enrolling participants?

"Information posted on clinicaltrials.gov shows that this particular medical study is no longer actively recruiting patients; the trial was first published on January 1st 2024 and last modified on December 7th 2023. Despite this, there are currently 415 other studies searching for volunteers."

Answered by AI

Is eligibility for this medical trial restricted to those over the age of 80?

"The target demographic for this clinical trial is ages 18 to 75. There are 37 trials targeting individuals under 18 and 287 studies focusing on those aged 65 or older."

Answered by AI
~33 spots leftby Dec 2026